Dr. Jeffrey William Johnson, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 109 S Burr Blvd, Kewanee, IL 61443 Phone: 309-852-2885 Fax: 309-854-6410 |
Dr. Dennis J Gerleman, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 320 Tenney St, Kewanee, IL 61443 Phone: 309-852-6555 Fax: 309-852-6554 |
Mr. Gordon M Pointer, DO Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 627 East 2nd St, Kewanee, IL 61443 Phone: 309-852-6514 Fax: 309-856-5705 |
Pointer Chiropractic, Llc. Chiropractor Medicare: Medicare Enrolled Practice Location: 627 E 2nd St, Kewanee, IL 61443 Phone: 309-852-6514 Fax: 309-856-5705 |
Dr. Susan Marie Kaufman, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 109 N Tremont St, Kewanee, IL 61443 Phone: 309-854-6666 Fax: 309-856-5034 |
Charles C Gerleman Dc Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 320 Tenney St, Kewanee, IL 61443 Phone: 309-852-6555 Fax: 309-852-6554 |
Susan Marie Neuhalfen Neuhalfen Chiropractic Clinic Chiropractor Medicare: Medicare Enrolled Practice Location: 109 N Tremont St, Kewanee, IL 61443 Phone: 309-856-5034 Fax: 309-856-5034 |
Vandevelde Wellness Center Sc Chiropractor Medicare: Medicare Enrolled Practice Location: 615 Hollis St, Kewanee, IL 61443 Phone: 309-852-3939 Fax: 309-852-3911 |
Johnson Chiropractic Clinic, P.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 109 S Burr Blvd, Kewanee, IL 61443 Phone: 309-852-2885 Fax: 309-854-6410 |
Dr. Tauni L Koning, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 921 Rose St, Kewanee, IL 61443 Phone: 309-853-3261 Fax: 309-856-6750 |
News Archive
It is almost axiomatic in medicine that the study of rare disorders informs the understanding of more common, widespread ailments.
A first-of-its-kind study from Emergency Nurses Association, published online in the Journal of Emergency Nursing, finds that moral distress in the emergency department is an experience distinct to those working in that specific environment, compared to nurses in other specializations.
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
A federal grant puts the University of North Texas Health Science Center at the heart of an effort to combat Fort Worth's stubbornly high infant mortality rates.
› Verified 2 days ago